fosphenytoin

(redirected from Fosphenytoin sodium)
Also found in: Medical.

fos·phen·y·to·in

 (fŏs′fĕn′ĭ-tō′ĭn, -fə-nĭt′ō-)
n.
A prodrug that is metabolized to phenytoin and administered parenterally for the treatment of seizures.

[Alteration of phos(phorus) + phenytoin.]
References in periodicals archive ?
Drug Profiles discussed in this report are ADD-405008, AMPX-0079, fosphenytoin sodium, SAGE-217, SAGE-547, SAGE-689, Small Molecule to Inhibit GABA Transaminase for Migraine and Status Epilepticus and TG-4155.
Fosphenytoin sodium was approved for intravenous (IV) or intramuscular (IM) administration in the treatment of SE, as well as for the prevention or treatment of seizures in patients who cannot take oral AEDs.
The Joint Venture has now placed purchase orders for five Injectable ANDA products, one for Fosphenytoin Sodium, two for Ondansetron, one for Flumazenil and one for an expected ANDA approval in the near term.
Akorn-Strides, LLC today announced the approval of an ANDA for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL (equivalent to Phenytoin Sodium).
GeneraMedix offers Fosphenytoin Sodium Injection, USP, 50 mg PE*/mL in 2 and 10 mL vials, preservative free.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fosphenytoin Sodium Injection, 100 mg, 2 mL and 500 mg, 10 mL vials, USP, the generic equivalent of Pfizer's Cerebyx([R]).
After the close of the first quarter, the company received an Abbreviated New Drug Application (ANDA) approval for Clindamycin Injection and a tentative approval for Fosphenytoin Sodium Injection from the U.
Fosphenytoin Sodium Injection can be used for the control of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery.